Small extracellular vesicles derived from mesenchymal stem/stromal cells as drug-delivery tools for anti-cancer drugs
- 27 July 2024
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 99
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Bioorthogonally surface‐edited extracellular vesicles based on metabolic glycoengineering for CD44‐mediated targeting of inflammatory diseasesJournal of Extracellular Vesicles, 2021
- Isolation and Profiling of Circulating Tumor‐Associated Exosomes Using Extracellular Vesicular Lipid–Protein Binding Affinity Based Microfluidic DeviceSmall, 2019
- TPP1 Delivery to Lysosomes with Extracellular Vesicles and their Enhanced Brain Distribution in the Animal Model of Batten DiseaseAdvanced Healthcare Materials, 2019
- Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomesInternational Journal of Cancer, 2018
- Exosomes in bodily fluids are a highly stable resource of disease biomarkersProteomics – Clinical Applications, 2015
- Urinary extracellular microvesicles: Isolation methods and prospects for urinary proteomeProteomics, 2014
- Human adipose tissue‐derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastomaInternational Journal of Cancer, 2011
- Visualizing of the cellular uptake and intracellular trafficking of exosomes by live‐cell microscopyJournal of Cellular Biochemistry, 2010
- Hemolytic mechanism of dioscin proposed by molecular dynamics simulationsJournal of Molecular Modeling, 2009
- The Mechanism of Electroporation and Electrofusion in Erythrocyte Membranes1989